A ruling in favor of generic drugmaker Hikma will make it harder for brand-name manufacturers to block cheaper alternatives.
Days after shareholders of Amarin sided with activist investor Sarissa Capital, removing Chairman Per Wold-Olsen and adding seven new members to its board in a resounding vote, the troubled Irish ...
Amarin Corporation plc (NASDAQ: AMRN) , a company committed to advancing the science of cardiovascular disease worldwide, applauds the recent FDA approval of injectable apolipoprotein C-III (APOC3) ...
In an opinion authored by Justice Jackson earlier this month, a unanimous Supreme Court recently reversed the Federal Circuit and held that ...
A little more than a year after Hikma Pharmaceuticals accused Amarin of “deliberately and meticulously” hamstringing supplies of the main ingredient in its only marketed drug, Vascepa, to thwart ...
Amarin Corporation plc announced a conference call scheduled for July 30, 2025, at 8:00 a.m. ET, to discuss its second quarter 2025 financial results and recent strategic initiatives, featuring ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Amarin Corporation (NASDAQ:AMRN) shares are trading higher Wednesday after the company released a business update and announced a conditional share repurchase program. Amarin estimates preliminary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results